Evaluating the Diagnostic Performance of MR Cytometry Imaging in Differentiating Benign and Malignant Breast Tumors
Journal of Magnetic Resonance Imaging · 2025-08 · 62 (2) · 521-533
DOI: 10.1002/jmri.29757 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Magnetic Resonance Imaging, online erschienen am 11.03.2025. Verfasst von Fan Liu und 10 weiteren Autor:innen. Beteiligte Einrichtung: Center for Biomedical Imaging Research, School of Biomedical Engineering, Tsinghua University, Beijing, China. Hauptthemen laut MEDLINE: Breast Neoplasms, Diffusion Magnetic Resonance Imaging. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 46 Literaturangaben. Gefördert von: National Key Research and Development Program of China, National Natural Science Foundation of China.
Abstract (Originalsprache)
Background
MR cytometry is a class of diffusion‐MRI‐based methods that characterize tumor microstructures at the cellular level. It involves multicompartmental biophysical modeling of multi‐b and multiple diffusion time data to generate microstructural parameters, which may improve differentiation of benign and malignant breast tumors.
Purpose
To implement MR cytometry imaging with transcytolemmal water exchange (JOINT and EXCHANGE) to differentiate benign and malignant breast tumors, and to compare the classification efficacy of IMPULSED, JOINT, and EXCHANGE. Study Type Prospective. Subjects 115 patients with pathologically confirmed breast tumors (25 benign and 90 malignant). Field Strength/Sequence 3T; pulsed gradient spin‐echo (PGSE) diffusion‐weighted imaging (DWI) and oscillating gradient spin‐echo (OGSE) DWI at 25 and 50 Hz. Assessment Tumor regions were delineated by two radiologists on DWI. Time‐dependent ADC and microstructural parameters (cell diameter , intracellular volume fraction , water exchange rate constant , extracellular diffusivity and intracellular intrinsic diffusivity ) were calculated. Classification performance was assessed in the original cohort and in an age‐adjusted cohort (excluding older malignant patients to eliminate significant age differences). Statistical Tests Mann–Whitney U‐tests compared benign and malignant tumor values. Multivariable logistic regression used a stepwise approach based on the likelihood ratio test. The area under the receiver operating characteristic (AUC) was computed and compared by using the DeLong test.
Results
In the full analysis (25 benign, 90 malignant), microstructural parameters from methods incorporating transcytolemmal water exchange (JOINT and EXCHANGE) demonstrated superior performance (AUC: ADC, 0.822; IMPULSED, 0.840; JOINT, 0.902; EXCHANGE, 0.905). Combining different metrics further improved classification (AUC: IMPULSED [, ], 0.942; JOINT [, ], 0.956; EXCHANGE [, ], 0.954; [], 0.927). These improvements were also observed in the age‐adjusted analysis (25 benign, 42 malignant). Data Conclusion MR cytometry outperformed ADC in distinguishing benign and malignant breast tumors. Incorporating transcytolemmal water exchange into biophysical modeling further improved its diagnostic performance. Evidence Level: 1 Technical Efficacy: Stage 2
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Center for Biomedical Imaging Research, School of Biomedical Engineering, Tsinghua University, Beijing, China.
- Qinghai University Affiliated Hospital, Xining, China.
- Tsinghua Shenzhen International Graduate School, Tsinghua University, Shenzhen, China.
- MR Collaborations, Siemens Healthineers, Beijing, China.
- MR Research Collaboration Team, Siemens Healthineers AG, Erlangen, Germany.
- Institute of Imaging Science, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
ORCID-Profile: Fan Liu, Junzhong Xu, Diwei Shi, Hua Guo
Förderung
- National Key Research and Development Program of China
- National Natural Science Foundation of China
Zitieren
APA
Liu, F., Wu, L., Luo, X., Li, S., Wang, Y., Zhong, W., Feiweier, T., Xu, J., Shi, D., Bao, H., & Guo, H. (2025). Evaluating the Diagnostic Performance of MR Cytometry Imaging in Differentiating Benign and Malignant Breast Tumors. Journal of Magnetic Resonance Imaging, 62(2), 521-533. https://doi.org/10.1002/jmri.29757
Vancouver
Liu F, Wu L, Luo X, Li S, Wang Y, Zhong W, et al. Evaluating the Diagnostic Performance of MR Cytometry Imaging in Differentiating Benign and Malignant Breast Tumors. Journal of Magnetic Resonance Imaging. 2025;62(2):521-533. doi:10.1002/jmri.29757
BibTeX
@article{Liu2025,
author = {Liu, Fan and Wu, Lei and Luo, Xinyi and Li, Sisi and Wang, Yishi and Zhong, Wen and Feiweier, Thorsten and Xu, Junzhong and Shi, Diwei and Bao, Haihua and Guo, Hua},
title = {Evaluating the Diagnostic Performance of MR Cytometry Imaging in Differentiating Benign and Malignant Breast Tumors},
journal = {Journal of Magnetic Resonance Imaging},
year = {2025},
volume = {62},
number = {2},
pages = {521--533},
doi = {10.1002/jmri.29757}
}
EUVIMED